Published July 6, 2023
| Version 1.0
Journal article
Open
The Challenges for Regulating Medical Use of ChatGPT and Other Large Language Models
Creators
- 1. Center for Advanced Studies in Biomedical Innovation Law, University of Copenhagen, Copenhagen, Denmark and Centre for Law, Medicine, and Life Sciences, University of Cambridge, Cambridge, England.
- 2. Institute of Translational Medicine, Swiss Federal Institute of Technology Zurich (ETH Zurich), Zurich, Switzerland
- 3. Harvard Law School, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics, Harvard University, Cambridge, Massachusetts
Description
Plain language summary: This Viewpoint discusses how regulators across the world should approach the legal and ethical challenges, including privacy, device regulation, competition, intellectual property rights, cybersecurity, and liability, raised by the medical use of large language models.
Notes
Peer-reviewed manuscript accepted for publication of: T. Minssen, E. Vayena, and I. G. Cohen, 'The Challenges for Regulating Medical Use of ChatGPT and Other Large Language Models', JAMA, vol. 330, no. 4, pp. 315–316, Jul. 2023, doi: 10.1001/jama.2023.9651.
Final published version available at https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2023.9651
Files
Regulating ChatGPT for Medicine JAMA accepted.pdf
Files
(235.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:7f9b6ec2e261ecc14ad7a213f962207c
|
235.1 kB | Preview Download |
Additional details
Related works
- Is published in
- Journal article: 10.1001/jama.2023.9651 (DOI)